Keyphrases
Visceral Leishmaniasis
100%
Small Molecules
100%
Explant Model
100%
Leishmania Donovani
50%
Antileishmanial Activity
50%
Luciferase
50%
Leishmania
25%
Age of Infection
25%
Pathophysiologic
25%
Cell Population
25%
New Drugs
25%
Hamster
25%
Culture System
25%
Spleen
25%
Drug Efficacy
25%
High-throughput Screening
25%
Cytotoxicity
25%
Chemical Optimization
25%
Chemical Library
25%
Quinoline
25%
Parasite Replication
25%
In Vitro System
25%
Host-parasite Interaction
25%
Explant Culture
25%
Current Therapies
25%
Vehicle Control
25%
Amphotericin B
25%
Aromatics
25%
Parasite Load
25%
Phenothiazine
25%
Antiparasitic
25%
Alkaloids
25%
In Vivo Evaluation
25%
Index Ratio
25%
In Vitro Therapeutic Index
25%
Chemical Compounds
25%
Parasite Resistance
25%
HepG2 Cell Line
25%
Immunosuppressive Mechanisms
25%
Z-factor
25%
Evaluation Optimization
25%
Furan
25%
Terpenes
25%
Medicine and Dentistry
Ex Vivo
100%
Visceral Leishmaniasis
100%
In Vitro
50%
Luciferase
50%
Infection
25%
Cell Line
25%
Leishmania
25%
Cytotoxicity
25%
Drug Efficacy
25%
Therapeutic Window
25%
High Throughput Screening
25%
Host Parasite Interaction
25%
Immunosuppressive Drug
25%
Explant Culture
25%
Amphotericin B
25%
Leishmania donovani
25%
Parasite Load
25%
Phenothiazine
25%
Antiparasitic Activity
25%
Furan Derivative
25%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
100%
Lead Compound
100%
Luciferase
40%
Infection
20%
Leishmania
20%
Preclinical Study
20%
High-Throughput Screening
20%
Therapeutic Window
20%
Leishmania donovani
20%
Immunosuppressive Agent
20%
Amphotericin B
20%
Phenothiazine
20%
Antiparasitic Activity
20%
Host Parasite Interaction
20%
Furan Derivative
20%
Cytotoxicity
20%
Immunology and Microbiology
Visceral Leishmaniasis
100%
Explant
100%
Leishmania
25%
Cell Line
25%
Preclinical Study
25%
Cytotoxicity
25%
Drug Efficacy
25%
Parasite Load
25%
Immunosuppressive Drug
25%
High Throughput Screening
25%
Host Parasite Interaction
25%
Leishmania donovani
25%
Antiparasitic Agent
25%